Aspirin and Atrioventricular block third degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block third degree is reported as a side effect among people who take Aspirin (aspirin), especially for people who are male, 60+ old, also take Plavix, and have Nerve block.

The phase IV clinical study analyzes which people have Atrioventricular block third degree when taking Aspirin. It is created by eHealthMe based on reports of 622,087 people who have side effects when taking Aspirin from the FDA, and is updated regularly.

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,089 Aspirin users. Check the latest studies of Aspirin.

What is Atrioventricular block third degree?

Atrioventricular block third degree (heart block third degree) is found to be associated with 11 drugs and 142 conditions by eHealthMe. Check the latest studies of Atrioventricular block third degree.

On Aug, 11, 2026

622,087 people reported to have side effects when taking Aspirin.
Among them, 16 people (0.0%) have Atrioventricular block third degree.

Could Aspirin cause Atrioventricular block third degree?

Among these 16 people:

What is the gender of people who have Atrioventricular block third degree when taking Aspirin? *

female: 25 %
male: 75 %

What is the age of people who have Atrioventricular block third degree when taking Aspirin? *

What are other drugs people take besides Aspirin? *

What are other side effects people have besides Atrioventricular block third degree? *

Bradycardia (abnormally slow heart action): 6 people, 37.50%
Hypotension (abnormally low blood pressure): 5 people, 31.25%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 4 people, 25.00%
Cardiac Arrest: 4 people, 25.00%
Ventricular Fibrillation (abnormally irregular heart rhythm): 3 people, 18.75%
Acute Myocardial Infarction (acute heart attack): 3 people, 18.75%
Hyperkalemia (damage to or disease of the kidney): 2 people, 12.50%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 2 people, 12.50%
Fainting (loss of consciousness and postural tone): 2 people, 12.50%
Pericardial Effusion (fluid around the heart): 2 people, 12.50%

What are the existing conditions these people have? *

Percutaneous Coronary Intervention: 2 people, 12.50%
Parkinson's Disease: 2 people, 12.50%
Nerve Block (the interruption of signals travelling along a nerve): 2 people, 12.50%
Stable Angina (a constant chest pain): 1 person, 6.25%
Ill-Defined Disorder: 1 person, 6.25%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 6.25%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 6.25%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.25%
Allergic Rhinitis: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Aspirin and have Atrioventricular block third degree?

- Check whether Atrioventricular block third degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aspirin:

Aspirin (632,089 reports)

Browse all side effects of Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block third degree:

Atrioventricular block third degree (11 drugs)

Browse all the conditions that are associated with Atrioventricular block third degree:

Atrioventricular block third degree (142 conditions)

Related publications that referenced our studies

Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on aspirin (the active ingredients of Aspirin) and Aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.